LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer. Recommended Stories Delta cuts service allowing Congress to bypass TSA lines until funding is restored FCC quickly approves Tegna-Nexstar merger after states sought to block it Acting DOJ antitrust chief denies Paramount-WBD merger will be approved for political reasons